SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001126234-18-000084
Filing Date
2018-05-09
Accepted
2018-05-09 15:13:24
Documents
52
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nlnk-20180331.htm   iXBRL 10-Q 1117342
2 CEO CERTIFICATION a2018331-10qxex311.htm EX-31.1 14588
3 CFO CERTIFICATION a2018331-10qxex312.htm EX-31.2 14582
4 SECTION 1350 CERTIFICATION a2018331-10qxex321.htm EX-32.1 9395
10 GRAPHIC nlnk-20180331_g1.jpg GRAPHIC 245252
  Complete submission text file 0001126234-18-000084.txt   4510237

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nlnk-20180331.xsd EX-101.SCH 21913
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nlnk-20180331_cal.xml EX-101.CAL 44540
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nlnk-20180331_def.xml EX-101.DEF 144045
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nlnk-20180331_lab.xml EX-101.LAB 360973
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nlnk-20180331_pre.xml EX-101.PRE 240938
11 EXTRACTED XBRL INSTANCE DOCUMENT nlnk-20180331_htm.xml XML 566640
Mailing Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010
Business Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010 515-296-5555
NEWLINK GENETICS CORP (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35342 | Film No.: 18817953
SIC: 2834 Pharmaceutical Preparations